LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis.

Photo by nci from unsplash

The article "LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis, by T. Xu, C.-L. Liu, T. Li, Y.-H. Zhang, Y.-H. Zhao, published in Eur Rev… Click to show full abstract

The article "LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis, by T. Xu, C.-L. Liu, T. Li, Y.-H. Zhang, Y.-H. Zhao, published in Eur Rev Med Pharmacol Sci 2019; 23 (11): 4698-4705-DOI: 10.26355/eurrev_201906_18062-PMID: 31210308" has been retracted by the authors as they state that due to a larger sample size, their new experimental results are inconsistent with the data showed in Figure 1B of the manuscript. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/18062.

Keywords: progression prostate; prostate cancer; lncrna tug1; aggravates progression; cancer predicts; tug1 aggravates

Journal Title: European review for medical and pharmacological sciences
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.